Helicos to Cut 14 More Positions; Lapidus Steps Down as Chairman | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences said Tuesday after the close of the market that as part of its ongoing restructuring plan it will cut another 14 positions from the firm as it aims to reduce its operating costs.

In addition, it disclosed that Chairman Stanley Lapidus has stepped down from his post but will remain a member of the board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.